JSM2026
Back to all people

Oleksandr Sverdlov

Novartis Pharmaceuticals Corporation
2 appearances in the program

Sessions & presentations

Rethinking Randomization: Bias, Ethics, and the Future of Clinical Trial Design.
Presentation: The Prevalence of Response Adaptive Randomization in Clinical Trials.
Invited Paper Session · Sun, Aug 2 , 2:00 PM
Speaker
Advancing Clinical Research with Large Language Models: Unveiling EHR Insights and Efficiency
Presentation: From Data Scarcity to Data-Driven Hope: Systematizing Drug Repurposing for Rare Diseases with Large Language Models
Invited Paper Session · Thu, Aug 6 , 10:30 AM
Speaker
↑